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Lack of netrin-4 modulates 
pathologic neovascularization in 
the eye
Norbert Kociok1,*, Sergio Crespo-Garcia1,*, Yong Liang1,2, Sabrina V. Klein1, 
Christina Nürnberg1, Nadine Reichhart1, Sergej Skosyrski1, Eva Moritz3, Anna-Karina Maier1, 
William J. Brunken4, Olaf Strauß1, Manuel Koch3 & Antonia M. Joussen1
Netrins are a family of matrix-binding proteins that function as guidance signals. Netrin-4 displays 
pathologic roles in tumorigenesis and neovascularization. To answer the question whether netrin-4 acts 
either pro- or anti-angiogenic, angiogenesis in the retina was assessed in Ntn-4−/− mice with oxygen-
induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), mimicking hypoxia-
mediated neovascularization and inflammatory mediated angiogenesis. The basement membrane 
protein netrin-4 was found to be localised to mature retinal blood vessels. Netrin-4, but not netrin-1 
mRNA expression, increased in response to relative hypoxia and recovered to normal levels at the end 
of blood vessel formation. No changes in the retina were found in normoxic Ntn-4−/− mice. In OIR, 
Ntn-4−/− mice initially displayed larger avascular areas which recovered faster to revascularization. 
Ganzfeld electroretinography showed faster recovery of retinal function in Ntn-4−/− mice. Expression of 
netrin receptors, Unc5H2 (Unc-5 homolog B, C. elegans) and DCC (deleted in colorectal carcinoma), was 
found in Müller cells and astrocytes. Laser-induced neovascularization in Nnt-4−/− mice did not differ 
to that in the controls. Our results indicate a role for netrin-4 as an angiogenesis modulating factor in 
O2-dependent vascular homeostasis while being less important during normal retinal developmental 
angiogenesis or during inflammatory neovascularization.
The retina is a complex system composed of highly specialised primary sensory cells (photoreceptors) and neu-
ronal cells as well as blood vessels. Previous research on vascular disease in the retina has focused mainly on the 
role of vascular alterations in onset and development of disease. However, little attention has been given to the 
contribution of neurovascular interactions and coupling1.
Throughout the body, blood vessels and neuronal cells build complex systems that are anatomically and 
patho-physiologically intertwined; in the periphery of the body larger nerves are dependent on vascularization to 
ensure nutrition and oxygen supply, whereas arteries depend on innervation2. This mutually beneficial interaction 
has been shown to be necessary for development of neuronal tissues, with axonal path finding molecules such as 
netrins controlling both vessel morphogenesis and angiogenesis3. Netrins are a family of laminin-related extra-
cellular matrix (ECM) molecules with homology to the short arm of laminin molecules. They function as long 
range guidance signals, acting in early embryogenesis regulating the migration of neurons and the axon growth 
cones4,5 and have been shown to induce neurite growth6. In mammals, five members of the netrin family have been 
identified: netrin-14, netrin-37,8, netrin-46,9 netrin-G1 and netrin-G210,11. Netrin-1, -3 and -4, are secreted into the 
ECM, while netrin-G1 and -G2 are bound to the cell surface via a glycosylphosphatidylinositol link.
The functional role of the newest member, netrin-4, is not well understood. Netrin-4, a 628 amino acid protein6, 
is similar in size and secondary structure to that of the other netrins; however, in terms of its primary structure, 
netrin-4 appears to be a distant relative. The amino acids of its globular domain are more closely related to that of 
the laminin β -chains9. In vitro, netrin-4 promotes neurite growth from E14 rat olfactory bulb explants, suggesting 
it may be important as a haptotactic factor promoting axonal elongation or as a substrate for neuronal migration6. 
In addition, netrin-4 is located in the basement membranes of blood vessels and is therefore thought to play a key 
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role in angiogenesis6,9. Netrin-4 is highly expressed in the retina. This expression occurs in all ocular tissues as a 
component of the basement membranes12.
In line with other members of the netrin family, which have been implicated to play a role in various diseases, 
netrin-4 seems to be important mainly for tumours and pathologic neovascular tissues: it serves as a prognostic 
marker in tumours and is reported to delay/decrease their development, seemingly through restricting blood ves-
sel growth13. Despite accumulating evidence suggesting a role for netrin-4 in angiogenesis13–15, its exact function 
remains controversial; for example, netrin-4 morpholino knock-down in embryonic zebrafish results in altered 
blood vessel formation16, whereas Park et al.17 have observed only a weak expression of zebrafish netrin-4 during 
embryonic development. Other observations showed an altered netrin-4 expression related to cancer development 
and pathological vessel growth: in an in vivo model of diabetic mouse limb ischemia, angiogenesis was promoted 
following cerebral ischemia18. In the retina, netrin-4 expression is driven by hypoxia, further highlighting its patho-
logic function19. In addition, netrin-4 is up-regulated in VEGF-stimulated endothelial cells, reducing pathological 
angiogenesis in vitro and in laser-induced choroidal neovascularization14.
Here we studied the specific angiogenic function of netrin-4. We employed a netrin-4 deficient mouse model, 
with clinical relevance for pathologic neovascularization in the retina and choroid, to test the hypothesis that 
netrin-4 plays an important regulatory role in pathologic angiogenesis while having a less important role in 
developmental angiogenesis.
Results
Differential expression of netrin-4 and netrin receptors in the wild type mouse retina during 
postnatal development. Due to accumulating evidence that netrin-4 is involved in embryonic develop-
ment, we investigated the hypothesis that netrin-4 is a regulator of angiogenesis, and examined retinal netrin-4 
expression during normal postnatal development in mice using immunohistochemistry. While netrin-4 dep-
osition in the basement membrane of the retina has been examined in a prior study12; we specifically studied 
netrin-4 expression with reference to the retinal vascular development which develops entirely postnatally20,21. 
At P6, netrin-4 expression was not detected in retina sagittal sections and flat mounts; however, staining of the 
hyaloid artery and its branches was observed in retinal flat mounts (Fig. 1a). Sparse staining for netrin-4 in the 
larger vessels of the retinal vasculature was found beginning at P10 (Fig. 1a). There was a notable regression of 
the hyaloid artery from P10 to P17. While the peripheral retina was already fully vascularized at P10, there was 
Figure 1. Netrin-4 expression in WT mice and phenotype of Ntn-4−/− retina. (a) Vessel development and 
netrin-4 expression in WT and Ntn-4−/− mice. Vessels were visualised with Isolectin-IB4 staining in both 
genotypes (left and right panel), netrin-4 was stained only in WT mice (middle panel) from P6 to P17. No 
obvious expression of netrin-4 is detected at P6 in WT mice. Only the persistent hyaloid artery stained positive 
for netrin-4. While the retina is almost fully vascularized at P10 and P14, the netrin-4 staining is still limited 
to the large vessels. Vascularization of the Ntn-4−/− mice does not differ from WT. At P17 there is netrin-4 
expression throughout the retinal vasculature up to the capillary level. The insert shows a preferential netrin-4 
staining of arterioles. a = arteries, v = veins (b) Co-staining against netrin-4 and Isolectin-IB4 in flat-mounts of 
WT retinas at P17. Expression of netrin-4 was found in the main branching retinal vessels and the superficial 
capillaries (left panel) but not in the intermediate and the deep capillaries (right panel). Scale bar indicates 
100 μ m. (c) Co-staining against netrin-4 and Isolectin-B4 on sections from WT mice retinas at P21. Netrin-4 
expression is present at the level of Bruch´s membrane, but now also in the larger intermediate and deep retinal 
capillaries. Scale bar indicates 50 μ m.
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netrin-4 staining initially only in large vessels. At P17, netrin-4 staining was visible throughout the retinal vascu-
lature up to the capillary level; staining in superficial layers of the arterial side in the vascular tree was prominent, 
but absent from deeper layers (Fig. 1b). At P21 Netrin-4 expression was also present in the deep capillaries and 
the ocular basement membranes, including Bruch´s membrane (Fig. 1c). These observations indicate netrin-4 
expression is associated with the maturation of postnatal blood vessels and is preferentially concentrated in the 
arterial and micro vessel basement membranes during vessel development. In the adult retina, netrin-4 expres-
sion was more evident on arterioles than on veins (Fig. 1a, insert and Suppl. Fig. 1). Identification of retinal arter-
ies and veins was done morphologically as described22.
Effect of netrin-4 on the postnatal development of the retinal vasculature in Ntn-
4−/−mice. The differential netrin-4 expression might indicate a minor role of netrin-4 in the early formation 
of blood vessels which is in accordance with Li et al.12, who suggested that netrin-4 plays a very minor role in 
normal eye development. Thus, we investigated the effect of netrin-4 deficiency on retinal vasculature and studied 
the formation of retinal blood vessels in netrin-4 deficient mice (Ntn-4−/−) at various time points of postnatal 
development (P6-P21), again using immunostaining (Fig. 1a, right panel). Lack of netrin-4 staining of Ntn-4−/− 
retinal flat mounts at P6 and in adult mice confirmed the absence of netrin-4 in this mouse line (Suppl. Fig. 2). 
The retinal vasculature remained largely unaltered exhibiting, as in WT mice, incomplete vascularization at P6 
(Suppl. Fig. 3) and fully vascularized retinas from P10 on. Branching of the vessels as well as capillary formation 
appeared as in the wild type (Fig. 1a, right panel).
In both mice genotypes, co-staining of neovascular tufts (Isolectin-IB4) and pericytes (NG2) revealed a normal 
pericyte distribution in the retinal vessels during physiological conditions. We detected a pronounced pericyte 
staining in the neovascular tufts (Suppl. Fig. 4). Significant differences between the two genotypes were not detected. 
Moreover, partial co-staining of isolectin IB4 and laminin γ 3 in the WT also showed only limited association 
between laminin γ 3 and the pathological vessels (Suppl. Fig. 5).
Thus we confirmed that netrin-4 is not required for physiological development of retinal blood vessels12.
Faster recovery from OIR vascular damage in Ntn4−/− mice. The developmental sequence of 
netrin-4 expression and its restricted spatial expression suggests that it might play a role in the stabilisation 
of mature blood vessels and perhaps vascular remodelling. Therefore, we undertook an analysis of the role 
of netrin-4 in pathological blood vessel formation using an oxygen induced retinopathy (OIR) mouse model 
(Fig. 2a). Retina flat-mounts at P10, P14 and P17 demonstrated a similar time course of netrin-4 expression as at 
normoxia (Fig. 1). In addition, immunostaining revealed netrin-4 expression in the large tortuous retinal vessels 
on P14 and P17 with prominent staining of the areas of retinal neovascularization (Fig. 2b). Especially the neo-
vascular tufts exhibit a prominent co-staining of netrin-4 and Isolectin-IB4 (Fig. 2b, insert) at a time point when at 
normoxia only the superficial capillaries are stained. Compared to wild-type mice, Ntn4−/− mice exhibited similar 
neovascular tufts at P17 (Fig. 2b, lower row). By P28, the pathological tufts and vascularization vanished both in 
WT as well as in Ntn-4−/−mice.
As an indicator of blood vessel development, the size of the avascular zone was measured in retina flat-mount 
preparations. The avascular zone in P10 WT was significantly smaller compared to that in Ntn-4−/− mice 
(30.9% ± 1.2%; N = 4 versus 39.9% ± 1.7%; N = 5; p = 0.005) (Fig. 2c,d). By P12, the avascular zone was equally 
large in the retina of both mouse strains (31.7% ± 2.2% (N = 5) and 31.3% ± 2.7% (N = 3); p = 0.926), but at later 
time points was significantly reduced in size in Ntn-4−/− mice: At P14 the mean avascular zone in the WT was 
26.5% ± 1.8% (N = 6) compared to 17.4% ± 1% (N = 3) in Ntn-4−/− mice (p = 0.013). At P17 the mean avascular 
zone in WT animals measured 18.8% ± 1.3% (N = 17) of total retina surface area compared to 14.6% ± 0.8% 
(N = 22) in Ntn-4−/− mice (p = 0.009) (Fig. 2d). Thus in the absence of netrin-4, closure of the avascular area by 
new vessels is accelerated.
Since in the Ntn-4−/− mice this occurred faster, we also analysed the neovascular tufts in more detail. 
Neovascular retinal tufts were identified as hyper fluorescent irregular formed vessels at P17 (Fig. 2e) as indi-
cated23,24. Some neovascular vessels in Ntn-4−/− mice appear as large branched pathological vessels compared to 
the more circumscribed neovascular tufts in WT and showed a tendency to be more reduced in Ntn-4−/− mice 
compared to WT; however, this didn’t turn significant (Fig. 2f). However, an analysis of tufts in H/E-stained 
sections showed a significant reduction in the amount of epiretinal nuclei in Ntn-4−/− mice compared to the WT 
(Suppl. Fig. 6).
Next to test if the faster revascular response after OIR in Ntn-4−/− mice had a functional consequence, sco-
topic ERG was performed on wild-type and Ntn4−/− mice (Fig. 3) using standard ISCEV conditions. ERGs were 
recorded at P17 and P28 (5 and 16 days after oxygen treatment, respectively). At P17, there were no differences in 
the a-wave parameters between the two mouse strains suggesting comparable photoreceptor function, whereas the 
b-wave latency increased in the Ntn-4−/− mice (105.3 μ V ± 7.6 μ V, N = 8 versus 90.6 μ V ± 6.4 μ V, N = 8, p = 0.002) 
(Fig. 3a–d). At P28, the Ntn-4−/− mice showed significantly increased a-wave (58.7 μ V ± 44, N = 8, p = 0.012) 
and b-wave (458 μ V ± 63 μ V, N = 8, p = 0.006) amplitude, but still increased b-wave latency (88.5 ± 2.1, n = 8, 
p = 0.027) than the WT mouse (517 ms ± 55 ms, N = 8, 362 ms ± 40 ms, N = 8, and 83.3 ms ± 5.7 ms, N = 8, respec-
tively) (Fig. 3e–h). Thus, the absence of netrin-4 accelerates at first the vasobliterative phase of OIR as well as the 
recovery from these effects. As shown in Suppl. Fig. 7 this functional difference is not due to a different baseline 
response in genetically different mice but due to a difference in OIR response. 
Differential regulation of netrin-4 mRNA expression at OIR compared to netrin-1 mRNA 
expression. We next analysed whether expression of netrin-4 is differentially regulated during patho-
logic angiogenesis. Expression of netrin-4 and netrin-1 were examined under normoxia and relative hypoxia 
at P14, P17, and P21 in WT mice using qPCR. Under normoxic conditions, netrin-4 mRNA expression 
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was stable from P14 to P21 at a Δ Δ CT value of about 2.3 × 10−04, N = 3 (Fig. 4a, black). On the other hand, 
netrin-1 mRNA expression remained at a 10 times lower but also constant level of about 2.1 × 10−05 (P14: 
2.08 × 10−5 ± 1.43 × 10−6; N = 3) between P14 and P17 in the WT, before declining further to 1.5 × 10−05 at 
P21 (Fig. 4b). In Ntn-4−/− mice a similar expression pattern of netrin-1 mRNA was observed: Starting at P14 
with a Δ Δ CT-value of 1.54 × 10−5± 2.82 × 10−6 (N = 4) and decreasing to 8.3 × 10−6± 1.06 × 10−6; (N = 4) 
at P21. There is no compensating netrin-1 overexpression in Ntn-4−/− mice due to the missing of netrin-4. OIR 
significantly increased the expression of netrin-4 mRNA at P14 (3.31 × 10−4 ± 1.34 × 10−5; N = 3 p = 0.024) and 
at P17 (3.61 × 10−4 ± 3.77 × 10−5; N = 4; p = 0.029). At P21, netrin-4 mRNA expression rates reached a simi-
lar level as in untreated retinas (3.32 × 10−5 ± 8.69 × 10−6; p = 0.191) (Fig. 4a, grey). There is an opposite reac-
tion of the netrin-1 mRNA expression to OIR than of netrin-4 expression (Fig. 4b): In the WT retina (Fig. 4b, 
solid line), netrin-1 expression at P14 starts at the same level as at normoxia (1.77 × 10−5 ± 1.776× 10−6; N = 3), 
but then decreases at P17 (0.94 × 10−5 ± 2.42 × 10−6; N = 4) and increases again to the normoxic level at P21 
(1.24 × 10−5 ± 2.7 × 10−6, N = 5). In Ntn-4−/−,(Fig. 4b, interrupted line) netrin-1 mRNA expression decreases 
even more after OIR and is significant lower than at normoxia (P14: 7.1 × 10−6 ± 9,07 × 10−7; N = 3; p = 0.0049; 
Figure 2. Faster morphological recovery from OIR vascular damage in Ntn-4−/− mice. Netrin-4 expression 
and development of retinal blood vessels in Ntn-4−/− and their respective WT mice after oxygen challenge. 
(a) Experimental paradigm: oxygen exposure lasted from P7 to P12. (b) Retina flat-mounts at P10, P14 
and P17.Co-staining against netrin-4 (red) and Isolectin- IB4 (green) demonstrate netrin-4 expression on 
the large retinal vessels at P10, P14 and P17 with prominent staining in the areas of pathological retinal 
neovascularization (Insert: composite of netrin-4 staining (red) and Isolectin- IB4 staining (green)). Ntn-
4−/− mice also demonstrate a prominent neovascular response on P17 (right panel). (c) Example of avascular 
area quantification in Ntn-4−/− and their respective WT controls at P10. Red line outlines the capillary edges 
between vascular and non-vascular areas to define the area used for quantification. (d) Quantification of the 
avascular areas of Ntn-4−/− and their respective WT mice. Avascular area is given as percentage of total retinal 
area. At P10 the avascular area was significantly larger in Ntn-4−/− mice but decreased faster in Ntn-4−/− mice 
than in the WT, beginning at P14 (n = 4). *p < 0.05; **p < 0.01. (e) Isolectin-IB4 stained retinal flat mounts at 
P17 of WT (left) and  Ntn 4−/− mice (right). Neovascular tufts are highlighted in white. (f) Quantification of 
neovascular tufts. The neovascular tufts showed a tendency to be more reduced in Ntn 4−/− mice compared to 
the WT. N = number of flat-mounts.
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P17: 3.4 × 10−6 ± 7,38 × 10−7; N = 3; p = 0.0015; P21: 5.0 × 10−6 ± 1.22 × 10−6; N = 3; p = 0.0122). Also after OIR 
there is no compensating netrin-1 mRNA overexpression in Ntn-4−/−.
Differential VEGF-A mRNA expression after OIR in Ntn4−/− mice. It is well established that VEGF is 
a fundamental regulator of normal and abnormal angiogenesis25. Therefore, mRNA levels of VEGF-A expression 
were measured in oxygen treated and untreated WT and netrin-4 knock-out mice (Fig. 4c). Under normoxic con-
ditions, VEGF-A mRNA expression in WT (solid line) was constant from P14 to P21: 1.3 × 10−2 ± 4.84 × 10−4 
Figure 3. Faster physiological recovery from OIR vascular damage in Ntn-4−/− mice. Ganzfeld-ERGs at 
P17 and P28 in oxygen-treated mice (a) Scotopic a-waves in response to a single flash of 10 cds/m2 in Ntn-4−/− 
(red) and WT (black) at P17 (b) Comparison of a-wave amplitude at 10mcds/m2 (left panel) and latency (right 
panel). (c) Scotopic b-waves in response to single flash 10 mcds/m2 in Ntn-4−/− (red) and WT (black) at P17 
(d) Comparison of b-wave amplitude at 10 mcds/m2 (left panel) and latency (right panel). (e) Scotopic a-waves 
in response to single flash of 10 cds/m2 in Ntn-4−/− (red) and WT (black) at P28 (f) Comparison of a-wave 
amplitude at 10 mcds/m2 (left panel) and latency (right panel). (g) Scotopic b-waves in response to single flash 
10 mcds/m2 in Ntn-4−/− (red) and WT (black) at P28 (h) Comparison of b-wave amplitude at 10 mcds/m2 (left 
panel) and latency (right panel). All recordings: N = 8 eyes of 4 mice; *p < 0.05; **p < 0.01.
www.nature.com/scientificreports/
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at P14, 1.44 × 10−2 ± 2.54 × 10−3 at P17, and 1.18 × 10−2 ± 2.69 × 10−3 at P21 (N = 3 for each time point). A 
similar and constant VEGF-A mRNA expression was also noted in Ntn-4−/− (interrupted line) in normoxia: 
P14: 1.55 × 10−2 ± 2.47 × 10−3, P17: 1.41 × 10−2 ± 2.29 × 10−3, P21: 1.02 × 10−2 ± 2.07 × 10−3 (N = 4 for all time 
points). After oxygen treatment, VEGF-A mRNA expression in both genotypes (WT: solid line, Ntn-4−/−: inter-
rupted line) increased significantly as expected and had a maximum at P14 (WT: 2.15 × 10−2 ± 3.04 × 10−3; N = 3 
and Ntn-4−/−: 2.42 × 10−2 ± 0.91 × 10−3, N = 3). Also in both genotypes VEGF-A expression decreased at P17 
(WT: 1.71 × 10−2 ± 1.71 × 10−3; N = 4 and Ntn-4−/−: 2.02 × 10−2 ± 3.17 × 10−3; N = 3) thereafter reaching the 
normoxic level at P21 (WT: 1.35 × 10−2 ± 1.52 × 10−3; N = 5 and Ntn-4−/−: 1.34 × 10−2 ± 1.53 × 10−3; N = 3)
Thus, irrespective of the absence of netrin-4, VEGF-A mRNA expression follows its normal course in the OIR 
model.
Activation of netrin receptor expressing glia cells after OIR. As demonstrated above, differential reg-
ulation of netrin-4 has a role in the stability of mature blood vessels and is the prerequisite for pathologic blood 
vessel formation in OIR. We now aimed to identify which retinal cell type is able to react to changes of netrin-4 in 
the basement membrane. Although netrin-4 receptors are not well established, the expression of cognate receptors 
of other netrin family members was investigated. By RT-PCR and Western Blot analysis, Liu and colleagues have 
recently shown that UNC5B (=Unc5H2), UNC5C, UNC5D, DCC, neogenin, and A2b are all expressed in the reti-
nas of mice26. But only Unc5H2 was upregulated after OIR. We therefore concentrated on Unc5H2 and only on one 
of the non-reacting receptors (DCC) to identify their cellular location. In normoxia at P14, glial fibrillary acidic 
protein (GFAP) is staining prominently astrocytes. On the other hand, after OIR at P14 and P17, astrocytes and 
Müller cell hyperplasia can be detected by GFAP and glutamine synthetase (GS)27, indicating gliosis that involves 
both astrocytes and Müller cells (Fig. 5). Immunostaining for both Unc5H2 and DCC showed widespread staining 
throughout the retina. The patterns of staining are consistent with expression of these two receptors by both Müller 
cells and astrocytes (Fig. 5). After OIR, Unc5H2 is localized in radial fibres running throughout the ONL, a pattern 
which is more distinctly attributable to up-regulation by Müller cells (Fig. 5a, right panel) under these conditions 
compared to normoxia (Fig. 5a, left panel). In normoxic retina, DCC immunoreactivity in the GCL appears to 
co-localize with GFAP suggesting expression in astrocytes (Fig. 5a, left panel), and these pattern does not change in 
relative hypoxia (Fig. 5a, right panel). Thus it is likely that Müller cells or astrocytes in the inner retina can respond 
to changes in netrin-4 expression in the basal membrane.
GFAP and GS staining of retinal sections after OIR at P14 and P17 reveals GFAP localisation in astrocytes and 
Müller cells (Fig. 5a,b). Astrocyte and Müller cell hyperplasia is similar in both Ntn-4−/− and WT mice (Fig. 5b).
Reduced leakage area but similar scar area in the choroid of Ntn-4−/− mice after laser pho-
tocoagulation. Given that netrin-4 is differentially regulated under oxygen influence and Ntn-4−/− mice 
exhibited an altered blood vessel growth in the ROP model, it is likely that netrin-4 plays a general role in blood 
vessel homeostasis or pathological angiogenesis. To further explore a more general regulatory role of netrin-4 in 
neo-angiogenesis, we investigated laser-induced CNV in both WT and Ntn-4−/− mice.
One and two weeks following laser photocoagulation, fluorescein leakage from laser scars was quantified 
as a measure of new blood vessel formation. Leakage area as well as leakage integrated density measured in 
Ntn-4−/− mice and WT mice were significantly different two weeks after photocoagulation (Ntn-4−/−, 2.641×106 
pixel ± 701031, n = 27 vs WT, 4.805×106 pixel ± 106300; n = 29, p = 0.0358) (Fig. 6). In contrast, no significant 
differences were observed one week (Ntn-4−/−, 3.985×106  ± 696513 pixel; n = 27 vs WT, 4.296×106  ± 873013 
pixel; n = 19, p = 0.6717) after laser treatment. In contrast to the effect on vascular re-growth, there was no dif-
ference in the area of scar formation. Isolectin-IB4 staining in sclera flat-mounts revealed no significant differ-
ence (p = 0.2795) in the size of the laser scar area between the groups (24210 μ m ± 2730; n = 31, Ntn-4−/− vs 
35824 μ m ± 7536; n = 26, WT) (Fig. 6) two weeks after laser photocoagulation. These data indicate that netrin-4 
Figure 4. Differential regulation of netrin-4, netrin-1, and VEGF-A in OIR. (a) Comparison of netrin-4 
mRNA expression in oxygen treated (grey) and untreated (black) WT mice. Netrin-4 expression is significantly 
higher at P14 and P17 after oxygen treatment, and decreases at P21 to normoxic level. (b) Comparison of 
netrin-1 mRNA expression in oxygen treated (grey) and untreated (black) WT (solid line) and Ntn-4−/− mice 
(interrupted line). In contrast to netrin-4 and VEGF-A the mRNA expression of netrin-1 is lower after OIR 
and increases at P21 to normoxic level. (c) Comparison of VEGF-A mRNA expression in oxygen treated (grey) 
and untreated (black) WT (solid line) and Ntn-4−/− mice (interrupted line). As expected, the maximal VEGF-A 
mRNA expression after OIR is at P14 and decreases at P21 to normoxic level. The expression pattern of VEGF-A 
is very similar in WT mice and Ntn-4−/−. All measurements N ≥ 3 to 5, *p < 0.05; **p < 0.01; ***p < 0.001.
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has a minor impact in laser-induced choroidal neovascularization, a model in which neovascularization is strongly 
driven by inflammation and not by hypoxia.
Discussion
Using Ntn-4−/− mice, we demonstrate that differential expression of netrin-4 plays a role in pathophysiology of 
neovascularization and influences ischemia related but not inflammatory neovascularization. Analysis of the tem-
poral and spatial distribution of netrin-4 expression demonstrated that netrin-4 is anti-angiogenic and enriched 
in adult blood vessel basal lamina to maintain blood vessel stability.
During postnatal development of the WT retina, netrin-4 and netrin receptors are differentially expressed 
depending on the developmental status of the vasculature. Close to the time-point of blood vessel maturation, 
netrin-4 staining was found throughout the retinal vasculature up to the capillary level, but was more prominent 
in superficial layers of the arterial side in the vascular tree, albeit not in the deeper layers. These findings on a 
protein level are in line with the progression of netrin-4 mRNA-expression during vessel development. A constant 
netrin-4 mRNA levels are found at the late phase of retinal vessel formation (P14–P21). In accordance, analysis of 
retinal vascularization in netrin-4 deficient mice revealed that vessels and capillaries developed normally. Thus, 
netrin-4 expression is not associated with the early stages of postnatal blood vessel development, but instead with 
the termination of their development and is likely to be involved in stabilizing mature blood vessels. This implies, 
however, that there is no active role for netrin-4 in normal vascular development but is involved with neovascular 
events as predicted by Li et al.12.
Analysis of potential netrin-4 receptors also revealed a possible functional correlation with a role in stabilisation. 
Although it is not fully established that netrin-4 binds to the known receptors of the netrin family (e.g. Unc5H2 
and DCC), data obtained here suggest that retinal glial cells, Müller cells and astrocytes, express these proteins 
indicating that netrin-4 plays a role in mediating interactions between the vascular and the neuronal system, as is 
assumed for the other members of the netrin protein family. This result is a good starting point for further exploring 
neurovascular coupling in Ntn-4−/− retina undergoing vascular pathogenesis scenarios.
In contrast, to the minor role during retinal development, netrin-4 expression may, however, have a major 
impact on pathological blood vessel formation. The role of netrin-4 in hypoxia-driven pathologic neovasculariza-
tion in the OIR model was investigated in Ntn-4−/− and WT mice. After OIR the avascular zone was more rapidly 
closed in Ntn-4−/− mice as compared to WT. Moreover, in this sequel, the Ntn-4−/− retina showed faster functional 
Figure 5. Activation of GFAP and netrin receptor expressing glia cells after OIR. (a) Immunodetection in 
sections of GFAP (green) and the netrin receptors UNC5H2 or DCC (red) from WT retinas at P14 at normoxia 
(left panel) and after OIR (right panel). The patterns of staining are consistent with expression of these two 
receptors by both Müller cells and astrocytes. Astrocyte extensions in the GCL are marked “A”. Müller cell 
extensions in the outer plexiform layer are marked “M”. Cell extensions in the inner and outer nuclear layer 
are marked by arrowheads.The uniform localisation of DCC in astrocytes at normoxic conditions is irregular 
and spotty. Insert shows a detail of the co-staining. The positive staining in the outer segments (OS) of the 
photoreceptors is due to unspecific binding of the secondary antibody. Scale bar indicates 50 μ m. (b) GFAP 
staining of WT and Ntn-4−/− retinal sections after OIR. GFAP stains astrocytes and Müller cells. Activation of 
astrocytes and Müller cells looks similar in both Ntn-4−/− and WT. Nuclei were stained with DAPI. Bar scale 
indicates 50 μ m.
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recovery after OIR. At P17 rod function was similar in Ntn-4−/− and WT. On the other hand, Ntn-4−/− mice 
displayed reduced functionality of bipolar and Müller cells at this time point. In contrast, at P28 Ntn-4−/− mice 
displayed higher rod activity and comparable bipolar and Müller function to WT. However, the faster functional 
recovery in knock-out mice may not be solely due to vascular normalization. Directly improving neuronal cells 
functions cannot be ruled out, although it is difficult to separate them due to the intensive interaction between 
the nerve system and the vascular system.
Thus, absence of netrin-4 accelerates the hypoxia-driven blood vessel regression during the time of oxygen 
exposure but also the recovery from OIR, indicating netrin-4 is an anti-angiogenic factor. The latter conclusion 
was supported by analysing of time-dependent netrin-4 expression in OIR. After oxygen exposure, an increase in 
netrin-4 expression was observed at the mRNA at P17, as compared to controls. Since P17 in OIR is the period of 
highest pathological angiogenic activity, up-regulation of netrin-4 is likely one of the prerequisites for maturing 
vessels and thus normalisation of angiogenesis. Therefore, in the Ntn-4−/− mice the complete absence of netrin-4 
permits the faster recovery of the avascular area after OIR by allowing the faster sprouting of new and outgrowth 
of immature vessels, because maturation is delayed in this genotype.
The increased vessel loss in Ntn-4−/− mice at P10 may suggest that netrin-4 has an anti-apoptotic func-
tion. To date, only for netrin-1 in combination with its receptor UNC5B there is an anti-apoptotic func-
tion described28. In a tumor model, netrin-4 overexpression was shown to inhibit tumor growth. But, 
although this is associated with decreased tumor cell proliferation and enhanced tumor cell apoptosis 
in vivo, the authors could not show a direct effect on tumor proliferation and tumor apoptosis in vivo and in vitro29.
Bucher et al. 2013 found apoptosis in astrocytes during the hyperoxic phase between P8 and P10 in mice 
expressing H2B-GFP (green fluorescent protein fused to histone 2B) from the endogenous Pdgfra promoter30. Also 
retinal thinning in hypovascular and avascular regions were found in mice after OIR31, but it was not clear whether 
this occurred due to arrested retinal development and/or ischemia induced apoptosis. The possible involvement 
of netrin-4 with apoptosis would be an interesting topic for a further analysis of its function in the eye.
Analysis of time-dependent VEGF-A expression in Ntn-4−/− further supports the idea that netrin-4 expres-
sion plays a role in establishing an anti-angiogenic environment. During physiological postnatal development, 
expression of both netrin-4 and VEGF-A is constant from P14 to P21. As postulated earlier, given that netrin-4 
is potentially anti-angiogenic, its high level of expression may counterbalance a high VEGF-A expression levels 
and stabilise the mature vessels.
Figure 6. Lower leakage in Ntn-4−/− mice two weeks after laser photocoagulation but no different scar 
area. (a) SLO angiography of vessel leakage area two weeks after laser photocoagulation in WT and Ntn4−/−. 
There is a smaller leakage area (c) and integrated density (d) in Ntn4−/− mice. (b) Isolectin IB4 stained retinal 
flat mounts of laser scar area two weeks after laser photocoagulation in WT and Ntn4−/− mice. There is no 
difference in the laser scar area (e) between WT and Ntn4−/− mice. N is the number of leakage area, leakage 
integrated density, or scar area and came from three mice, each. Scale bar indicates 100 μ m. *p < 0.05, 
**p < 0.01.
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After oxygen challenge, the expression dynamics of netrin-4 and VEGF-A are quite similar. VEGF-A expression 
peaks at a time point (P14) when netrin-4 expression is also high. Thus, in OIR both VEGF-A and netrin-4 show 
a high and balanced expression to help normalizing angiogenesis. Netrin-4 may have a specific anti-angiogenic 
function as Netrin-1 does not show any compensatory regulation in Ntn4−/− mice.
Netrin-4 is required for maintenance of mature blood vessels and its expression needs to be balanced with the 
expression of VEGF in physiological as well as pathological angiogenesis.
Actually, in Ntn-4−/− retinas, the pathological vessels at P17 showed partly a different morphology than the 
WT. In Ntn-4 −/−, some neovascular vessels appear as large branched pathological vessels compared to the more 
circumscribed neovascular tufts in WT, with decreased cell numbers but with similar tuft area; highlighting a 
possible altered proliferation activity of endothelial cells during angiogenesis when netrin-4 is absent but VEGF-A 
level is still high. The similar pericyte distribution in neovascular tufts of WT and Ntn-4−/− indicates no direct 
influence of Netrin-4 on the interaction of pericyte and endothelial cells.
As discussed above, netrin-4 plays a role in physiological vascular stability and in the recovery of pathologic 
neovascularization after hyperoxic challenge. In order to analyse whether netrin-4 has a more general role in the 
regulation of neo-angiogenesis, we employed another model for neovascularization, the laser-induced CNV in both 
WT and Ntn-4−/− mice. The finding that the leakage area and the integrated leakage density of Ntn-4−/− mice was 
significantly increased (as compared to WT mice) only two weeks after photocoagulation but with no associated 
differences in the laser area, indicates a minor role for netrin-4 in laser-induced choroidal neovascularization14 , a 
model in which neovascularization is strongly driven by inflammation rather than hypoxia.
The temporal and spatial expression pattern of netrin-4 and its receptors in relation to VEGF-A expression 
together with the faster recovery after oxygen challenge in Ntn-4−/− mice allow us to postulate a model of netrin-4 
action in the retina. Results from the OIR model, in accordance with previous work in vitro19, suggest expression 
of netrin-4 is regulated by changes in oxygen tension. Furthermore, we suggested both Müller cells and astrocytes 
as sites of DCC and Unc5H2 expression, which would enable interaction with netrin-4 positive basement mem-
branes. Again, although the cognate receptors for netrin-1 are not yet established as receptors for netrin-4, their 
expression in Müller cells and astrocytes and perhaps retinal neurons, propose they have an interacting role in 
retinal angiogenesis. We postulate that smooth muscle and endothelial cells are the major source for netrin-4, as 
reported previously6. Taken these key observations together, we think that these cells enrich the basal membranes 
with netrin-4 to stabilise the mature vessels at the end of their development.
The hypothesised role of netrin-4 role in vessel stabilization and oxygen-tension dependent vascular homeo-
stasis aligns well with observations regarding a broader role of netrin-4 in disease, especially cancer32,29. Netrin-4 
has been identified as a prognostic marker for tumours33 and exhibits anti-tumorigenic potential, albeit through 
unknown mechanisms13,34. Netrin-4 application was shown to decrease intracellular signalling related controlling 
proliferation, but it could neither be linked to a specified cell type nor to a direct pathway13,34. Since tumour growth, 
in particular, depends on oxygen-driven blood vessel growth, we suggest that the netrin-4-dependent regulation 
of blood vessel stability explains these observations.
Material and Methods
Animals. All animal experiments were adhered to the ARVO Statement for the Use of Animals in Ophthalmic 
and Vision Research and were approved by governmental Animal Care and Use Committees (LaGeSo, Berlin).
Mice were not littermates. C57/Bl6J mice were purchased from Charles River (Wilmington, MA, USA) 
or Janvier (Cedex, France). Ntn-4−/− mice were generated as described12 and are on a C57BL/6J-background. 
The genotype was determined by PCR analysis of genomic DNA prepared from tail or ear samples. Primers 
used: wild type (WT) and null allele forward AGCAGCCTTTAAACATCCTGAG, WT allele reverse 
GAAAGCTCCGGGCAGACACTATGTG, and null allele reverse CAAATGTGTCAGTTTCATAGCC.
Animals were fed regular laboratory chow and water ad libitum. A 12-hour day–night cycle was maintained.
Mouse Model of Oxygen-Induced Retinopathy. To induce reproducible proliferative retinal neovas-
cularization in retinopathy of prematurity, the protocol by Smith et al.35) was performed under modified condi-
tions36. Mice - the nursing dam and her new-born pups were housed in room air conditions from postnatal day 
P0 to P7. On P7, the animals were exposed to 75% oxygen for 5 days and then, transferred back to room air. A 
special oxygen chamber (Model THF3384) was used (EHRET Labor- u. Pharmatechnik GmbH, Emmendingen, 
Germany). Surrogate nursing dams were provided if mother died - a rare incident. Control mice were maintained 
in room air. Pups were removed from their cages for retinal analysis on days P10, P12, P14, P17, and P21. All 
experiments were performed at least in triplicate for each time point. Only animals with a weight above 5 g at P14 
were included in the study37.
Laser-induced CNV Model and fluorescence angiography. To investigate the role of netrin-4 in cho-
roidal neovascularization (CNV), adult WT and Ntn-4−/− mice underwent laser exposure38.
An argon laser (Visulas 532 s, Carl Zeiss Meditec, Oberkochen, Germany) was used to set four to five distinct 
50 μ m wide spots (120 mW intensity, 100 ms duration with a wavelength of 532 nm) around the optic disc. Rupture 
of Bruch’s membrane was indicated by appearance of a bubble at the site of photocoagulation39. After two weeks, 
the treated eyes were investigated by means of a fluorescence angiography in order to evaluate leakage from the 
nascent pathological choroidal blood vessels. We followed the method developed by Ryan40, adapted for mice41. 
The animals were intraperitoneally injected with 200 μ l 5% fluorescein sodium (Alcon Pharma GmbH, Freiburg, 
Germany) and placed in front of the ophthalmoscope (Spectralis OCT, Heidelberg Engineering, Heidelberg, 
Germany). Images were analysed using ImageJ (NIH, USA) having into account leakage area and integrated density.
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Visualization and Quantification of Retinal Vascularization in Whole-Mounts. Eyes were enucle-
ated and fixed in 4% PFA solution for 15 minutes. The cornea was dissected with a circumferential limbal incision, 
followed by removal of the lens and vitreous. Four radial cuts were made to allow flattening and subsequently, 
retina was isolated by sectioning the optic nerve. Retinas were repeatedly washed and incubated in a block-
ing solution containing normal goat serum. Vasculature was detected and analysed using Alexa 488-conjugated 
GS Isolectin-IB4 (1:200; Thermo Fisher Scientific (Invitrogen), Waltham MA) as described38 (Table 1). Pericytes 
were detected using an antibody against NG2 (Table 1), a commonly extended marker42. Netrin-4 (Table 1) was 
detected according to Cellerino et al.43.
All retinas were mounted onto glass-slides and subjected to microscopy imaging with a standardised tech-
nique to compare vascular density and to analyse areas of neovascularization. Microscopes employed were MZ 
FLIII (Leica Microsystems, Bensheim, Germany) with a charge-coupled device (CCD) camera (C4742-95-12ER; 
Hamamatsu, Hamamatsu City, Japan) and Axio Imager M2 fluorescence microscope (Zeiss, Göttingen, Germany).
Analysis was run using the soft wares OpenLab (Improvision Inc., Lexington, MA, USA) and ZEN 2012 (Zeiss, 
Göttingen, Germany). The total avascular area (in pixels) was then determined and normalised to the total retina 
area and the percentage of the non-vascularized area was calculated using ImageJ (NIH, USA). All retinas were 
analysed in a masked fashion to minimise sampling bias.
Histology and immunohistochemistry on paraffin sections. Animals were sacrificed at settled time 
points, and eyes fixed in Methacarn (60% methanol, 30% 1,1,1 -trichlorethane, 10% acetic acid) overnight at room 
temperature (RT) or 4% PFA overnight at 4 °C and routinely processed for paraffin embedding. Sections (5 μ m) 
were used for immunohistological analysis. Some paraffin sections were subjected to standard hematoxylin-eosin 
(HE) staining for retinal structural analysis.
Immunodetection was performed on deparaffinised sections. Different antigen retrieval processes were 
applied before incubation with a blocking solution containing 5% BSA. Blood vessels were stained with GS 
Isolectin-IB4. Müller cell gliosis was detected via Glial Fibrillary Acidic Protein (GFAP) and via Glutamine 
synthetase (GS). Netrin-4 and its receptors Deleted in Colorectal Carcinoma (DCC) and Unc-5 Homolog 2 
(Unc5H2) specifications are in Table 1. All primary antibody incubations were performed overnight at 4 °C, but 
for anti-DCC and anti-Unc5H2, which incubation was extended up to 4 nights. After three washing steps with 
TBS, species-appropriate fluorescence-labelled secondary antibodies were applied for 1 h at RT (Table 2). Sections 
were mounted in Fluorescence Mounting Medium (DAKO, Hamburg, Germany) and examined using the Axio 
Imager M2 fluorescence microscope (Zeiss, Göttingen, Germany).
RNA Isolation and RT-PCR. Freshly isolated retinas were stored in RNAlater solution at − 20 °C until RNA 
isolation and then homogenized in lysis buffer (RNeasy Kit, Qiagen, Hilden Germany). RNA isolation and cDNA 
synthesis was performed according to the manufacturer’s instructions (Qiagen, Hilden, Germany). Expression 
levels of 6 calibration genes were measured in WT mice retinas, using the geNorm calculation tool V3.3, based on 
the recommendations of Vandesompele et al.44. Because GAPDH was found to be one of the most stable genes in 
our experiments, it was used to normalise gene expression levels.
The mRNA expression levels of VEGF-A, netrin-1, netrin-4, and GAPDH in the mouse retinas from different 
strains and experimental conditions were measured in triplicate by Real Time RT-PCR using the Rotor-Gene SYBR
Green PCR Kit (Qiagen, Hilden, Germany) on a Rotor-Gene Q (Qiagen, Hilden, Germany). Primer sequences 
are collected in Table 3. The analysis was repeated three times. To verify specific amplification, PCR products were 
subjected to melting curve analysis. Genomic DNA contamination was excluded by choosing primers hybridizing 
to different exons or spanning exon borders. Moreover, control amplification reactions that were performed with 
non-transcribed RNA as templates gave only background fluorescence. Quantification of the calibrated target 
genes was carried out using the comparative CT (threshold cycle, Δ Δ CT) method using Rotor-Gene Q software 
2.2.3 (Qiagen, Hilden, Germany) as described45. Only animals with comparable mean body weight per group 
Antibody Retrieval treatment Concentration Source
Rabbit anti-DCC Citrate Buffer 1:250 M. Koch
Rabbit anti-GFAP Proteinase K 1:250 Dako
Rabbit anti-GS Proteinase K 1:500 abcam
GS Isolectin-IB4 (AF488-conjugated) None 1:200 Invitrogen
Rabbit anti-NG2 (Cy3-conjugated) None 1:200 Millipore
Rabbit anti-Netrin-4 None 1:200-1000 M. Koch
Rabbit anti-Unc5H2 Citrate Buffer 1:500 M.Koch
Table 1.  Primary Antibodies for Immunodetection.
Antibody Concentration Source
Donkey anti-Rabbit (AF488-conjugated) 1:10000 Invitrogen
Goat anti-Rabbit (Cy3-conjugated) 1:5000 Dianova
Table 2.  Secondary Antibodies for Immunodetection.
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at the different time points were analysed (Table 4). There is no significant body weight difference between WT 
mice and Ntn-4−/− mice when comparing mice held at normoxia or treated with oxygen with the exception of 
P21 mice after OIR.
Electroretinography (ERG). Mice were dark-adapted overnight, pupils were dilated by tropicamide 0.5% and 
atropine 1%, and mice were anesthetised by injection of xylazine (15 mg/kg body weight) and ketamine (100 mg/kg). 
The animals were positioned on a warming table to maintain body temperature. A monopolar contact lens elec-
trode was used as recording electrode (for both eyes) and a subcutaneous fixed platin needle was the reference 
and ground electrode. For recording, the mouse was placed into a commercially available Ganzfeld bowl (Roland 
Consult, Brandenburg, Germany).
In the dark-adapted state, a flash series consisting of 10 steps started at –4.0 log cd • s/m− 2 and reached 0.48 
log cd • s/m− 2. The signal was amplified by 10.000 with a band pass filter from 1 to 300 Hz. Oscillatory potentials 
were obtained with flash Intensity 0.48 log cd s/m− 2 by band pass filtering from 100 to 500 Hz.
C-wave recordings were taken in the dark-adapted state, immediately after the scotopic ERG. Stimulus dura-
tion was 250 ms. Stimulus (green light) energy levels used were 0.48, 0.95 and 1.25 log cd • s/m− 2 with band pass 
filtering from 0.1 to 30 Hz.
For a-wave recording, 3 additional flash energies were applied: 0.97, 1.48 and 1.97 log cd s/m− 2.
After recording the a-wave, the background light (1.8 log cd m− 2) was turned on, the animals were further 
light-adapted for 10 minutes, and the photopic ERG was recorded using a series of flash energies (0.7 and 1.3 log 
cd • s/m− 2; band pass filtering 1-300 Hz; average of 10 recordings at 1.5 Hz).
Statistical Analysis
All results are expressed as the mean ± SEM. After testing for normal distribution (Shapiro–Wilks), the data 
were compared by unpaired T-test if the Levenne-test showed equal variance. Otherwise a non-parametric test 
(Whitney-Mann-U) was used. For ERG a Kruskal–Wallis test for independent samples was used. For qPCR-analysis 
a power analysis (GPower 3.1.7, Franz Faul, University of Kiel) confirmed that with the used data and SEM a 
sample size of 3 is enough for a power > 0.95. Differences were considered to be statistically significant when P 
values were less than 0.05.
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